Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori

Table 2

Major outcomes of RAK and BRAK for Helicobacter pylori eradication.

	RAK	BRAK	value
Eradication rate, n/N (%)
Intention-to-treat	59/81 (72.8)	63/81 (77.8)	0.47
Per protocol	59/79 (74.7)	63/77 (81.8)	0.28
Compliance, n/N (%)	79/81 (97.5)	77/81 (95.1)	0.40
Side effect, n/N (%)	41/81 (50.6)	41/81 (50.6)	—

7 patients had an unknown H. pylori status after treatment (3 in RAK group, 4 in RBAK group).